Filed: 11/14/2024ACC: 0001839435-24-000008
📋 What this filing means
OCTAGON CAPITAL ADVISORS LP filed this quarterly 13F‑HR report disclosing 41 equity positions with a total reported market value of $642.90M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
41
Positions
$642.90M
Total AUM (reported)
88.20M
Total Shares
Allocation by class
COM$338.80M52.7%
SPONSORED ADS$137.55M21.4%
COM NEW$75.38M11.7%
COM PAR $.01$50.14M7.8%
COM CL A$27.87M4.3%
COM SHS$9.19M1.4%
CL A ORD SHS$2.61M0.4%
Portfolio Concentration
Top 3$192.10M29.9%
4–10$248.55M38.7%
11–25$167.73M26.1%
Rest$34.52M5.4%
Top 3 weight
29.9%
Top 10 weight
68.5%
Voting Authority Distribution
Total shares with voting rights: 87.95M
Sole
Full voting authority
87.95M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole41
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings41
Rows:
APELLIS PHARMACEUTICALS INC
SOLEShares3.01M
TypeSH
Market value$86.72M
13.49%
Sole
3.01M
Shared
0.00
None
0.00
VERONA PHARMA PLC
SOLEShares1.84M
TypeSH
Market value$52.80M
8.21%
Sole
1.84M
Shared
0.00
None
0.00
STRUCTURE THERAPEUTICS INC
SOLEShares1.20M
TypeSH
Market value$52.58M
8.18%
Sole
1.20M
Shared
0.00
None
0.00
INSMED INC
SOLEShares686.82K
TypeSH
Market value$50.14M
7.80%
Sole
436.82K
Shared
0.00
None
0.00
DIANTHUS THERAPEUTICS INC
SOLEShares1.75M
TypeSH
Market value$47.82M
7.44%
Sole
1.75M
Shared
0.00
None
0.00
ARRIVENT BIOPHARMA INC
SOLEShares1.98M
TypeSH
Market value$46.45M
7.22%
Sole
1.98M
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS PLC
SOLEShares2.01M
TypeSH
Market value$32.17M
5.00%
Sole
2.01M
Shared
0.00
None
0.00
NUVATION BIO INC
SOLEShares12.17M
TypeSH
Market value$27.87M
4.34%
Sole
12.17M
Shared
0.00
None
0.00
CORBUS PHARMACEUTICALS HLDGS
SOLEShares1.11M
TypeSH
Market value$23.00M
3.58%
Sole
1.11M
Shared
0.00
None
0.00
OCULAR THERAPEUTIX INC
SOLEShares2.42M
TypeSH
Market value$21.10M
3.28%
Sole
2.42M
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares870K
TypeSH
Market value$19.79M
3.08%
Sole
870K
Shared
0.00
None
0.00
PERSPECTIVE THERAPEUTICS INC
SOLEShares1.42M
TypeSH
Market value$18.99M
2.95%
Sole
1.42M
Shared
0.00
None
0.00
MIND MEDICINE MINDMED INC
SOLEShares3.02M
TypeSH
Market value$17.17M
2.67%
Sole
3.02M
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares1.30M
TypeSH
Market value$14.09M
2.19%
Sole
1.30M
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares552K
TypeSH
Market value$14.05M
2.19%
Sole
552K
Shared
0.00
None
0.00
PHARVARIS N V
SOLEShares620.47K
TypeSH
Market value$11.49M
1.79%
Sole
620.47K
Shared
0.00
None
0.00
DYNE THERAPEUTICS INC
SOLEShares262.73K
TypeSH
Market value$9.44M
1.47%
Sole
262.73K
Shared
0.00
None
0.00
TAYSHA GENE THERAPIES INC
SOLEShares4.57M
TypeSH
Market value$9.19M
1.43%
Sole
4.57M
Shared
0.00
None
0.00
GOSSAMER BIO INC
SOLEShares9.19M
TypeSH
Market value$9.06M
1.41%
Sole
9.19M
Shared
0.00
None
0.00
ALLOVIR INC
SOLEShares11.20M
TypeSH
Market value$9.06M
1.41%
Sole
11.20M
Shared
0.00
None
0.00
EYEPOINT PHARMACEUTICALS INC
SOLEShares1.09M
TypeSH
Market value$8.74M
1.36%
Sole
1.09M
Shared
0.00
None
0.00
PRAXIS PRECISION MEDICINES I
SOLEShares130K
TypeSH
Market value$7.48M
1.16%
Sole
130K
Shared
0.00
None
0.00
MINERALYS THERAPEUTICS INC
SOLEShares600K
TypeSH
Market value$7.27M
1.13%
Sole
600K
Shared
0.00
None
0.00
REGULUS THERAPEUTICS INC
SOLEShares4.26M
TypeSH
Market value$6.69M
1.04%
Sole
4.26M
Shared
0.00
None
0.00
VENTYX BIOSCIENCES INC
SOLEShares2.39M
TypeSH
Market value$5.21M
0.81%
Sole
2.39M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
APELLIS PHARMACEUTICALS INCSOLE | COM | 3.01M | SH | $86.72M 13.49% | 3.01M | 0.00 | 0.00 |
VERONA PHARMA PLCSOLE | SPONSORED ADS | 1.84M | SH | $52.80M 8.21% | 1.84M | 0.00 | 0.00 |
STRUCTURE THERAPEUTICS INCSOLE | SPONSORED ADS | 1.20M | SH | $52.58M 8.18% | 1.20M | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 686.82K | SH | $50.14M 7.80% | 436.82K | 0.00 | 0.00 |
DIANTHUS THERAPEUTICS INCSOLE | COM | 1.75M | SH | $47.82M 7.44% | 1.75M | 0.00 | 0.00 |
ARRIVENT BIOPHARMA INCSOLE | COM | 1.98M | SH | $46.45M 7.22% | 1.98M | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALS PLCSOLE | SPONSORED ADS | 2.01M | SH | $32.17M 5.00% | 2.01M | 0.00 | 0.00 |
NUVATION BIO INCSOLE | COM CL A | 12.17M | SH | $27.87M 4.34% | 12.17M | 0.00 | 0.00 |
CORBUS PHARMACEUTICALS HLDGSSOLE | COM NEW | 1.11M | SH | $23.00M 3.58% | 1.11M | 0.00 | 0.00 |
OCULAR THERAPEUTIX INCSOLE | COM | 2.42M | SH | $21.10M 3.28% | 2.42M | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 870K | SH | $19.79M 3.08% | 870K | 0.00 | 0.00 |
PERSPECTIVE THERAPEUTICS INCSOLE | COM NEW | 1.42M | SH | $18.99M 2.95% | 1.42M | 0.00 | 0.00 |
MIND MEDICINE MINDMED INCSOLE | COM NEW | 3.02M | SH | $17.17M 2.67% | 3.02M | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 1.30M | SH | $14.09M 2.19% | 1.30M | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | COM | 552K | SH | $14.05M 2.19% | 552K | 0.00 | 0.00 |
PHARVARIS N VSOLE | COM | 620.47K | SH | $11.49M 1.79% | 620.47K | 0.00 | 0.00 |
DYNE THERAPEUTICS INCSOLE | COM | 262.73K | SH | $9.44M 1.47% | 262.73K | 0.00 | 0.00 |
TAYSHA GENE THERAPIES INCSOLE | COM SHS | 4.57M | SH | $9.19M 1.43% | 4.57M | 0.00 | 0.00 |
GOSSAMER BIO INCSOLE | COM | 9.19M | SH | $9.06M 1.41% | 9.19M | 0.00 | 0.00 |
ALLOVIR INCSOLE | COM | 11.20M | SH | $9.06M 1.41% | 11.20M | 0.00 | 0.00 |
EYEPOINT PHARMACEUTICALS INCSOLE | COM NEW | 1.09M | SH | $8.74M 1.36% | 1.09M | 0.00 | 0.00 |
PRAXIS PRECISION MEDICINES ISOLE | COM NEW | 130K | SH | $7.48M 1.16% | 130K | 0.00 | 0.00 |
MINERALYS THERAPEUTICS INCSOLE | COM | 600K | SH | $7.27M 1.13% | 600K | 0.00 | 0.00 |
REGULUS THERAPEUTICS INCSOLE | COM | 4.26M | SH | $6.69M 1.04% | 4.26M | 0.00 | 0.00 |
VENTYX BIOSCIENCES INCSOLE | COM | 2.39M | SH | $5.21M 0.81% | 2.39M | 0.00 | 0.00 |
Page 1 of 2